First Citizens Bank & Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

First Citizens Bank & Trust’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$675K	Buy	2,300 +866	+60%	+$246K	0.01%	390
2026 Q1	$400K	Buy	+1,434	New	+$413K	0.01%	484
2020 Q3	–	Sell	-586	Closed	-$265K	–	379
2020 Q2	$265K	Sell	586 -230	-28%	-$101K	0.02%	281
2020 Q1	$286K	Buy	816 +124	+18%	+$45.6K	0.03%	231
2019 Q4	$256K	Sell	692 -21	-3%	-$7.4K	0.02%	283
2019 Q3	$237K	Sell	713 -1,018	-59%	-$332K	0.03%	306
2019 Q2	$541K	Buy	1,731 +11	+0.6%	+$3.29K	0.06%	246
2019 Q1	$526K	Buy	1,720 +474	+38%	+$128K	0.06%	243
2018 Q4	$289K	Hold	1,246	–	–	0.04%	302
2018 Q3	$390K	Buy	+1,246	New	+$387K	0.04%	264
2013 Q4	–	Sell	-1,929	Closed	-$227K	–	384
2013 Q3	$227K	Buy	1,929 +61	+3%	+$7.19K	0.01%	998
2013 Q2	$210K	Buy	+1,868	New	+$219K	0.01%	982

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

First Citizens Bank & Trust's BIO Position: Q2 2026 in Review

First Citizens Bank & Trust increased its Bio-Rad Laboratories Class A (BIO) stake by 60% in Q2 2026, buying an estimated $246K and bringing the position to 2,300 shares worth $675K. The position accounts for 0.01% of the portfolio, ranked #390.

First Citizens Bank & Trust first reported a position in BIO in Q2 2013 and has held it in 12 quarters since. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

First Citizens Bank & Trust held 2,300 shares of Bio-Rad Laboratories Class A worth $675K as of Q2 2026.
First Citizens Bank & Trust bought 866 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $246K.
Bio-Rad Laboratories Class A made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #390 holding.
First Citizens Bank & Trust first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 12 quarters since.
400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.